Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jul 12;5(8):513-515.
doi: 10.1021/acsptsci.2c00122. eCollection 2022 Aug 12.

Diabetes and its Complications

Simon Matoori  1
Affiliations
Editorial

Diabetes and its Complications

Simon Matoori. ACS Pharmacol Transl Sci. .
No abstract available

PubMed Disclaimer

References

    1. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2014, 37 (Suppl. 1), S81–S90. 10.2337/dc14-S081. - DOI - PubMed
    1. Sun H.; Saeedi P.; Karuranga S.; Pinkepank M.; Ogurtsova K.; Duncan B. B.; Stein C.; Basit A.; Chan J. C. N.; Mbanya J. C.; Pavkov M. E.; Ramachandaran A.; Wild S. H.; James S.; Herman W. H.; Zhang P.; Bommer C.; Kuo S.; Boyko E. J.; Magliano D. J. IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Res. Clin. Pract. 2022, 183, 109119.10.1016/j.diabres.2021.109119. - DOI - PMC - PubMed
    1. Knudsen L. B. Inventing Liraglutide, a Glucagon-Like Peptide-1 Analogue, for the Treatment of Diabetes and Obesity. ACS Pharmacol. Transl. Sci. 2019, 2 (6), 468–484. 10.1021/acsptsci.9b00048. - DOI - PMC - PubMed
    1. Sloop K. W.; Briere D. A.; Emmerson P. J.; Willard F. S. Beyond Glucagon-like Peptide-1: Is G-Protein Coupled Receptor Polypharmacology the Path Forward to Treating Metabolic Diseases?. ACS Pharmacol. Transl. Sci. 2018, 1 (1), 3–11. 10.1021/acsptsci.8b00009. - DOI - PMC - PubMed
    1. Ala M.; Ala M. Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?. ACS Pharmacol. Transl. Sci. 2021, 4 (6), 1747–1770. 10.1021/acsptsci.1c00167. - DOI - PMC - PubMed

Publication types

LinkOut - more resources